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ETHANOL INCREASES INTERNAL DEFIBRILLATION 
THRESHOLD IN PIGS 
you H.&& ,h.fD, DoUg L Jones, PhD, FACC, George J. Klein, 
MD, FACC, Andrea Natale, MD, University of Western Ontario 
and Robarts Research Institute, London, Ontario, Canada 
Alcohol ingestion, particularly with high intake, has been 
associated with cardiac arrhythmias and may alter defibrillation 
efficacy in patients with implanted automatic defibrillators or 
who may require external defibrillation. To determine the effects 
of ethanol on defibrillation efficacy, triplicate defibrillation 
thresholds (DFT) were determined before and after intravenous 
administration of saline or one of 3 doses of ethanol in 4 group 
of pigs: 1) control, 6 mL& of saline injected over 10 min 
(n=12); 2) low dose, 6 mLfkg injected over 10 min (n=12); 3) 
mid dose, 0.45 mUkg-min infused for 30 min followed by 0.045 
mL&-min infused for 45 min, and 4) high dose, 0.6 mug-min 
infused for 30 min followed by 0,06 ml&g-min infused for 45 
min (n=l2). Defibrillation shocks were delivered through 3 
epicardial electrodes, using the sequential pulse technique. 
Electrophysiologic parameters and blood ethanol concentration 
were determined before and during infusions. DFT values of 
saline control and low ethanol dose groups were unchanged, but 
approached statistical significance for the mid ethanol dose 
(6.8a0.7 vs 7.620.9 J, 0.05cPcO.l) and were signifkantly 
elevated for the high ethanol dose (8.5~0.7 vs 11.2kl.l J, 
P~0.01). These results indicate that ethanol may contribute to 
lethal arrhythmias by altering cardiac electrophysiology and 
rendering ventricular fibrillation more difficult to terminate, 
IHPEDANCE-BASED ELECTRICAL CARDIOVERSION OF ATRIAL 
FIBRILLATION: A NEW METHOD FOR OPTIMAL ENERGY SELECTION. 
Michael C. Kienzle, Brian Olshansky, 
#ark D. Carlson, Albert L. Waldo, David Wilber, Ann M. 
Aschoff, Sally Birger, Laurie Fugatt, Susan Walsh, Karen 
Fox-Eastham, Hartin Rockwell, Francis Charbonnier, Univ. 
of Iowa, Iowa City, IA 
High energy levels are required for electrical 
cardioversion of aerial fibrillation in some patients. 
Recent studies have established the critical importance 
of transthoracic impedance as a determinant of shock 
success; patients who have high impedance require higher 
energies. Since impedance can be determined 
instantaneously by using microprocessor technology, 
impedance can be easily taken into account by basing 
cardioversion on the ratio of delivered energy to 
impedance, Ed/Z. To evaluate this approach, we 
determined Ed/Z for 218 shocks given electively for 
atria1 fibrillation. Results (*p<.OS by chi-square): 
Successful/Total Shocks 3 Success 
0.50-1.00 1/14* 7%* 
1.01-1.50 18/43 42% 
1.51-2.00 27/40 67% 
2.01-2.50 25/38 66% 
2.51-3.00 22/32 69% 
3.01-3.50 11/20 55% 
3.X-4.25 u/17 65% 
4.26-5.75 8/14 57% 
Thus, for initial shocks, an appropriate Ed/Z ratio is 
1.5-2.0; lower ratios yield inadequate success while 
higher ratios expose the patient to potential toxicity 
from excess energy without further improvement in 
success. We conclude that impedance-based electrical 
cardioversion is feasible and taking impedance into 
account should optimize success. 
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In a prospective sludy we investigated the different eleclrophysiologlcal 
characlerislics of class la, lb and class Ic anliarrhylhmic drugs and their 
effect on Ihe signal averaged ECG (S-ECG) and Halter Monitoring. We 
(herelore carried out acute oral lesling with 23 patients , all wllh high- 
grade ventricular arrhythmia (Lown grade IVb),. and angiographic&y 
documen1ed coronary artery disease or dilative cardiomyopathy. Every 
patient received on a single-blind. randomiwd baois 900 mg locainide. 300 
mg disopyramide and 300 mg flecainide versus placebo. The measurements 
w&e ca;;ied out immediately- before and two hburs after medication, using 
eleclrodes which remained fixed in olace We measured the duralion and 
voltage of the filtered QRS complex’ (IDRS). Slmullaneously we performed 
Holler monitoring. Drug efficacy was defined as a reduction of couplels by 
90% and ventricular lachycardias by 100%. 
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the increase In the duralion or Ihe fORS and In the Incidence of lale 
pOlenlialS was Signlflcanlly hlgher afler Ihe admlnlatrarion of flecainide 
than abler disopyramlde and focalnkle. 
There was no correlaliin betwwn Ihe changes of the parameters of the S- 
ECG and drug errtacy. 
Class lb and Ic AA show P dearth dirrerenl influence on the S-EC& Afrer the 
admlnistratlon of placebo and iocainlde. no significant changes or any 
measured parameters occurred. Disopyramide only showed a moderale 
increase in QRS duralion; one patient developed a new LP. In contrary, the 
changes of lhese parameters arler Ihe adminislralion of flecainide were 
more impressive. Flecainide showed a higher proportion of effectively 
treated palienls with 75%. compared lo disopyramide (58%) and (Qcainide 
(24%). We did not find any correlalion between Ihe results of Holler 
monitoring and S-ECG. 
